• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: PEGylated recombinant human tumor necrosis factor-related apoptosis inducing ligand
Date Designated: 09/05/2019
Orphan Designation: Treatment of chronic pancreatitis.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Theraly Fibrosis, Inc.
20271 Goldenrod Lane, Suite 2046
Germantown, Maryland 20876
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-